Anthony Vigil, MDa,b; Taylor Parnall, MDc; Clifford Qualls, PhDa,b; Robert Glew, PhDb; Robin Osofsky, MDd; Micah Guess, RNa; Lauren Mercer, MDb
Correspondence: Anthony Vigil (anthony.vigil@va.gov)
aNew Mexico Veterans Affairs Health Care System, Albuquerque
bUniversity of New Mexico School of Medicine, Albuquerque
cHarbor-UCLA Medical Center, Torrance, California
dOregon Health and Science University, Portland
Author contributions
Study conception and design: Vigil, Taylor; acquisition of data: Vigil, Taylor, Geuss, Mercer; analysis and interpretation of data: Vigil, Taylor, Osofsky, Qualls; drafting of manuscript: Vigil, Taylor; critical revision: Glew.
Author disclosures
The authors report no actual or potential conflicts of interest or outside sources of funding with regard to this article.
Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.
Ethics and consent
The New Mexico Veterans Affairs Health Care System Institutional Review Board approved this study (No. 15-H184).
The retrospective chart review nature of this study may have led to selection bias. Only a small number of patients received a transfusion, which may have skewed the data. This study population comes from a single VA medical center; this patient population may not be reflective of other VA medical centers or the US population as a whole. Given that NMVAHCS does not perform hepatic, esophageal, pancreas, or transplant operations, the potential savings to both the US and the VA may be overestimated, but this could be studied in the future by VA medical centers that perform more complex operations.
Conclusions
This study found that over a 4-year period routine postoperative hematocrit tests for patients undergoing elective general surgery at a VA medical center were not necessary. General surgeons routinely order various pre- and postoperative laboratory tests despite their limited utility. Reduction in unneeded routine tests could result in notable savings to the VA without compromising quality of care.
Only general surgery patients undergoing operations that carry a high risk for needing a blood transfusion should have a routine postoperative hematocrit testing. In our study population, the chance of an elective colectomy, cholecystectomy, or hernia patient needing a transfusion was rare. This strategy could eliminate a considerable number of unnecessary blood tests and would potentially yield significant savings.